These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3278857)

  • 21. Mitochondrial dysfunction in uremic cardiomyopathy.
    Taylor D; Bhandari S; Seymour AM
    Am J Physiol Renal Physiol; 2015 Mar; 308(6):F579-87. PubMed ID: 25587120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model.
    Fabris B; Fischetti F; Carretta R; Narducci P; Piccinini C; Calci M; Biagi A; Candido R; Bardelli M; Campanacci L
    J Hypertens Suppl; 1993 Dec; 11(5):S344-5. PubMed ID: 8158415
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneously occurring hypertrophic cardiomyopathy in the rat. II. Distribution of, and correlations between, various cardiac abnormalities in the WKY/NCrj and its related strains.
    Kuribayashi T; Mizuta T; Shimoo K; Kubota Y; Katsume H; Nakagawa M; Ibata Y
    Jpn Circ J; 1988 Oct; 52(10):1156-70. PubMed ID: 3210293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four-week oral toxicity study of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in uremic rats.
    Gomez M; Domingo JL; del Castillo D; Llobet JM; Corbella J
    Vet Hum Toxicol; 1995 Aug; 37(4):346-8. PubMed ID: 8540226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rat model for the study of growth failure in uremia.
    Chantler C; Lieberman E; Holliday MA
    Pediatr Res; 1974 Feb; 8(2):109-13. PubMed ID: 4810508
    [No Abstract]   [Full Text] [Related]  

  • 27. Dilated cardiomyopathy in acromegaly.
    O'Keefe JC; Wiseman JC; Wilmshurst EG
    Aust N Z J Med; 1985 Feb; 15(1):79-80. PubMed ID: 3859273
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodynamics of uremic anemia.
    Neff MS; Kim KE; Persoff M; Onesti G; Swartz C
    Circulation; 1971 Jun; 43(6):876-83. PubMed ID: 4931294
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of systemic blood pressure to myocardial remodeling in uremic rats.
    Fabris B; Carretta R; Fischetti F; Candido R; Calci M; Castellano M; Bardelli M; Campanacci L
    Hypertension; 1995 Aug; 26(2):321-6. PubMed ID: 7635542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular senescence determines endothelial cell damage induced by uremia.
    Carracedo J; Buendía P; Merino A; Soriano S; Esquivias E; Martín-Malo A; Aljama P; Ramírez R
    Exp Gerontol; 2013 Aug; 48(8):766-73. PubMed ID: 23624226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uremia in rats with normal kidneys: a model for the study of renal function in a uremic environment.
    Emmanouel DS; Lindheimer MD; Katz AI
    Kidney Int; 1977 Mar; 11(3):209-12. PubMed ID: 846073
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment.
    Edmondson SR; Baker NL; Oh J; Kovacs G; Werther GA; Mehls O
    Kidney Int; 2000 Jul; 58(1):62-70. PubMed ID: 10886550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
    Aksentijević D; Bhandari S; Seymour AM
    Kidney Int; 2009 Apr; 75(7):711-8. PubMed ID: 19177156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
    Larivière R; Moreau C; Rodrigue ME; Lebel M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone and the altered vascular response to norepinephrine in uremia.
    Collins J; Massry SG; Campese VM
    Am J Nephrol; 1985; 5(2):110-3. PubMed ID: 3993699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testicular function in experimental uremia.
    Handelsman DJ; Spaliviero JA; Turtle JR
    Endocrinology; 1985 Nov; 117(5):1974-83. PubMed ID: 3930220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Poli de Figueiredo CE; Pinheiro da Costa BE; Comerlato L; Micheli E; Barros E
    Nephrol Dial Transplant; 2001 Oct; 16(10):2110-1. PubMed ID: 11572912
    [No Abstract]   [Full Text] [Related]  

  • 38. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone and insulin-like growth factor in non-uremic acidosis and uremic acidosis.
    Kuemmerle N; Krieg RJ; Latta K; Challa A; Hanna JD; Chan JC
    Kidney Int Suppl; 1997 Mar; 58():S102-5. PubMed ID: 9067956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic abnormalities and uremic cardiomyopathy.
    Stewart GA; Gansevoort RT; Mark PB; Rooney E; McDonagh TA; Dargie HJ; Stuart R; Rodger C; Jardine AG
    Kidney Int; 2005 Jan; 67(1):217-26. PubMed ID: 15610245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.